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Sex is a significant epidemiological factor for several diseases. However, the role of sex in
the development and outcome of various infections has not been extensively studied with
the notable exception of urinary tract infections. We searched in the PubMed database to
identify articles that could provide relevant data regarding sex differences in the
incidence and severity of respiratory tract infections (RTIs). We extracted data from 84
relevant studies that provided information regarding sex differences in the incidence and
severity of RTIs. Females are more commonly affected with infections of the upper
respiratory tract, specifically sinusitis, tonsillitis, and otitis externa. On the other hand,
males are more commonly affected with otitis media, croup, and most important, lower
RTIs. It is also evident from the reviewed evidence that the course of most RTIs is more
severe in males than in females, leading to higher mortality in males, especially in
community-acquired pneumonia. In conclusion, the available data suggest that males are
more susceptible than females to most types of RTIs in all age groups (adults and children).
Overall, it seems that males develop RTIs more frequently than females, except for
sinusitis, otitis externa, and probably tonsillitis. Anatomic, lifestyle, behavioural, and
socioeconomic differences between males and females may explain the observed findings.
The role of sex hormones in the regulation of the immune system may also contribute to
the reported sex differences in the incidence and severity of the various types of RTIs,
especially in adolescents and adults.
& 2007 Elsevier Ltd. All rights reserved.Elsevier Ltd. All rights reserved.
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Sex differences in the incidence and severity of various
diseases are considered as basic epidemiologic data in most
medical fields. However, sex differences in the development
and outcome of diseases are poorly understood primarily
due to the fact that, during the past, many studies on
pathophysiology and disease prevention included only or
mainly males. Social factors that are more common in
females (including poverty),1 participation in the work
force, lifestyle characteristics such as smoking habits,2 and
socially defined sex roles may in part explain sex differences
in morbidity and mortality due to diseases. In addition,
biological factors like oestrogen production,3 cholesterol
levels,4 insulin deficiency or resistance,5 and obesity6 also
play a significant role in the pathophysiology of several
diseases. There is also evidence that women receive
different care than men for common chronic disorders,
while they make more visits to physicians for acute, self-
limited diseases. Nevertheless, females live longer than
males in most populations.7
Ischemic heart disease, hypertension, immunologically
mediated diseases, osteoporosis, diabetes mellitus, psycho-
logical disorders, and substance abuse are disorders that
are strongly associated with sex.1 On the other hand, there
has not been much discussion regarding the possible
sex differences in the incidence and severity of the various
infectious diseases, with the notable exception of urinary
tract infections. In this article, we sought to review
the available evidence in the literature regarding sex
differences in the incidence and severity of respiratory
tract infections (RTIs) that constitute a major proportion
of infectious disease-related morbidity and mortality in
humans.Literature search and study selection
We searched in the PubMed database for studies reporting
data regarding sex differences in the incidence and severity
of the upper and lower RTIs. Specifically, the keywords we
used in our literature searches were ‘‘common cold,
pharyngitis, laryngitis, croup, tonsillitis, otitis externa,
otitis media, mastoiditis, sinusitis, epiglottitis, bronchitis,
bronchiolitis, pneumonia, community-acquired pneumonia
(CAP), hospital-acquired pneumonia, nosocomial pneumonia
(NP), ventilator-acquired pneumonia, lung abscess, pleuraleffusion, empyema thoracis’’ combined with ‘‘sex or
gender’’.
The abstracts of the initially identified articles were
reviewed in order to select the relevant studies for more
detailed review. The decision to include a study was based
on whether data regarding our topic was mentioned in the
abstract. The complete texts of original articles that were
relevant to the focus of our review and we were able to
identify were read. When several studies were available,
only those with the larger population were included in the
review. Reviewed studies were limited to those that
referred to humans, were written in English, were published
between 1983 and September 2006, and included more than
30 patients. An exception to this rule was made if no study
regarding a specific RTI or its complications could meet all
the above criteria; in such a case we included data from
studies with a smaller number of patients. Studies referring
to RTIs of both adults and children were included.Data extraction
Data regarding the first author, year of publication, type of
study, study population, focus of study, male/female ratio of
occurrence of RTIs, sex differences in the severity of the
infections, suggested cause for the observed differences
(if any reported), other factors that may influence the
incidence and/or severity of RTIs, and the type of analysis
were extracted from the reviewed studies and tabulated.
The term ‘‘severity of infection’’ was defined by short-
term or long-term mortality for lower RTIs, while it refers to
prolonged course, recurrence, persistence, or complications
of disease for upper RTIS.Sex differences in the incidence and severity
of RTIs
In Tables 1 and 2, we present data from the reviewed studies
regarding sex differences in the incidence and severity of
upper and lower RTIs (URTIs8–38 and LRTIs),39–91 respectively.
Pharyngitis: There are limited available data regarding
sex differences in the incidence of pharyngitis. In one of
the two small studies retrieved,8 both of which refer to
children, the incidence of pharyngitis was a little higher
in males than females. The second study9 reported only
cases of subclinical pharyngitis, i.e. cases of asymptomatic
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Table 1 Sex differences in the incidence and severity of upper respiratory tract infections.
First author, year
of publication,
reference no.
Type of study; study
population
Focus of study M/F ratio Severity Proposed explanation Other factors/type of analysis
Pharyngitis
Lin M.H., 20038 Prospective study;
Taiwan, 2001–2002;
252 children, 1–15
years
Group A
Streptococcus;
pharyngitis in
children
1.29 (142:110) Age, month of the year
Gupta R., 19929 Prospective study;
New Delhi,
1990–1991; 141
children from whom
beta-haemolytic
streptococci were
isolated
Subclinical group-A;
streptococcal throat
infection in school
children
0.39 (Prevalence 15% of
the 639 examined boys:
38.9% of the 118
examined girls)
(Po0.001)
BV
Tonsillitis–peritonsillar abscess
Kvestad E.,
200510
Retrospective study;
Norway, 9479 twins
born between
January 1967 and
December 1979
Heritability of
recurrent tonsillitis
Significant predominance
of female cases of
recurrent tonsillitis. 0.62
(prevalence 8.8 in males
vs. 14.1% in females)
Matsuda A.,
200211
Retrospective study;
Tokyo, 1988–1999;
724 patients
Peritonsillar abscess 2.96 (541:183)
Thorp M.A.,
200012
Retrospective study;
Cape Town,
1991–1995; 7250
tonsillectomies, 111
hospital admissions
Tonsillectomy for
recurrent tonsillitis
and hospital
admission for acute
tonsillitis
Tonsillectomy patients:
overall M/F ratio 0.69
(2970:4280); F/M ratio in
patients 414 years, 3.22
95%CI 2.82–3.68. F/M
ratio for admission 1.85
Exposure of the mothers to
the URTIs of their children,
socio-economic factors,
differences in immunity
BV
Sinusitis
Shashy R.G.,
200413
Retrospective study;
Olmsted County,
Minnesota, 2000;
2405 patients
Prevalence of chronic
sinusitis
0.48 (778:1627);
prevalence per 100,000
1322:2585
Chen Y., 200314 Cross-sectional study;
Canada, 1996–1997;
3768 patients, 412
years
Epidemiology of
chronic rhinosinusitis
0.49 (1231:2537);
Prevalence 3.4%: 5.7%
Females have smaller ostia.
Increased health care-seeking
behaviour, subjective
sensitivity to symptoms by
women
Low income, allergy history.
Smoking significantly
associated with rhinosinusitis
only in females; MV
Sex
d
ifferences
in
resp
iratory
tract
infections
1847
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Table 1 (continued )
First author, year
of publication,
reference no.
Type of study; study
population
Focus of study M/F ratio Severity Proposed explanation Other factors/type of analysis
Stalman W.A.B.,
200115
Prospective study,
The Netherlands,
1993–1995; 177
patients, 15–65 years
Determinants for the
course of acute
sinusitis in adult
patients
Female sex was a factor
predictive of a prolonged
clinical course; BV: HR 0.7
Po0.01 MV: HR 0.60 95% CI
0.42–0.83
Women are more likely to
share their problems or poor
outcomes with their GP
Complaints for more than 14
days before inclusion,
headache, cold or cough as
reason for encounter, absence
of cervical adenopathy; BV
and MV
Lieu J.E., 200016 Data from a cross-
sectional survey;
USA, 1988–1994,
5848 patients, 417
years
Sinusitis and tobacco
use
0.66 (actual ratio
2315:3533); BV:
unadjusted RR for females
1.19 (CI 1.15–1.24);
prevalence 24.7%: 33.2%
MV: all race-ethnic groups
had a higher prevalence
with female sex
Race, higher income status,
higher educational level,
tobacco use. BV and MV
Croup
Segal A.O.,
200517
Retrospective study;
Ontario, 1988–2002;
44,820 patients, 0–4
years
Croup
hospitalisations
2.26 (31.057:13.763); In
children 0–1 years, boys
exhibited a relative risk of
2.08 over girls for croup
hospitalisations
Seasonality; MV
Osinusi K.,
199918
Prospective study;
Nigeria, 30-month
period; 35 children,
2–53 months
Acute laryngotracheobronchitis
in Nigerian children
1.7 (22:13)
Denny F.W.,
198319
Prospective study;
North Carolina,
1964–1975; 951 croup
cases in 903 children,
0–15 years
Croup in a paediatric
practice
1.43 (between the ages
6–12 months 1.73)
Incidence/100 children/
year 1.82:1.27
Epiglottitis
Chan K.O.,
200120
Retrospective study
Singapore,
1992–1999; 32
patients, of whom 31
adults
Acute epiglottitis in
the tropics
3 (24:8) Male sex was significant
predictor for airway
intervention (P 0.03) (ratio
11:0 with intervention, 13:8
without)
Age (peak in the 3rd decade)
Predictors for airway
intervention: stridor, presence
of airway compromise on
examination, ‘‘thumb sign’’;
BV
Stanley R.E.,
198821
Retrospective study;
Singapore General
Hospital, 1982–1985;
42 patients, 418
years
Acute epiglottitis in
adults
7.4 (37:5) Age (peak in the 6th decade)
M
.E.
Falagas
et
al.
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Otitis externa
Battikhi M.N.,
200422
Prospective study;
Jordan, 2001–2002;
180 patients
Otitis externa 1.25 (100:80) Seasonality
Rowlands S.,
200123
Retrospective study;
UK, 1997 40,661
episodes in 30,412
patients, 45 years
Otitis externa in UK 0.89 [(prevalence higher
in females (1.30% vs.
1.16%, Po0.001) in all
age groups up to the age
of 65 years]
Disease persistence more
common in women (F/M ratio
1.08 P ¼ 0.06); Recurrent
disease more common in men
(F/M ratio 0.90 P ¼ 0.001)
Greater consultation rate in
women 15–74 years Excessive
hair washing (likely to be more
common in females)
Seasonality; Eczema for
recurrent disease; MV
Otitis media
Acute otitis media
Hotomi M.,
200524
Prospective study;
Japan, 308 children,
10–86months, 277
with severe and 31
with non-severe
acute otitis media
(AOM)
Treatment and
outcome of severe
and non-severe AOM
1.22 (169:139) Children with severe disease
were more often males
(158:119, 57% males with
severe vs. 36% males with non-
severe AOM, Po0.05)
For severe AOM: colonisation
with pathogen (vs. no
pathogen); MV
Paradise J.L.,
199725
Prospective study;
Pittsburg, 1991–1995;
follow-up until age 2
years, 2253 children
Prevalence and risk
factors of OM during
the first 2 years of life
1.1 (1180:1073)
Proportions of days with
middle-ear effusion
higher in boys during 1st
and 2nd year, Po0.05
1st year: socio-economic
status, breastfeeding, number
of smokers; 2nd year: socio-
economic status, child
exposure index MV
Recurrent otitis media
Engel J.A.M.,
200526
Prospective study;
The Netherlands,
1999–2003; 73
children with
recurrent otitis
media with effusion
(ROME), 2–7 years
Birth characteristics
and ROME in children
Positive association
between ROME and male
sex OR 1.85, 95%CI
0.56–6.13
Low birth weight, low
gestational age, history of
incubator care, maternal
medication use during
pregnancy. MV
Luotonen M.,
199827
Prospective study;
Finland, 891 children
with recurrent otitis
media episodes
before the age of 3
years, examined at
the age of 9 years
Otitis media and
school achievement
Lower performance in
mathematical skills (risk ratios
1.2–1.4, P 0.04–0.02) and
classroom concentration (RR
1.4 P 0.02) for girls, worse
reading skills (RR 1.3 P 0.05)
and oral performance (RR 1.2
P 0.01) for boys
Differences between sexes in
the spatial functional
organisation and metabolism
of the brain for language and
behavior
MV
Bennett K.E.,
199828
Prospective study;
UK, all births in 1
week in 1970, 5 years
follow-up (over
13,000 births)
Factors influencing
children’s middle ear
disease (recurrent
acute otitis media,
RAOM, and otitis
media with effusion,
OME)
Male sex risk factor for hearing
difficulty (reflects OME
severity and persistence),
adjusted OR 1.26, P ¼ 0.001
and for conjoint hearing
difficulty/ear discharge, OR
1.43, P ¼ 0.014
Mother’s smoking habits, day
care attendance; MV
Hardy A.M.,
199329
Cross-sectional study;
US; childreno6 years
Child care
arrangements and
1.2 (percentages of
children with repeated
Age, race, medical history
(repeated tonsillitis, enlarged
Sex
d
ifferences
in
resp
iratory
tract
infections
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Table 1 (continued )
First author, year
of publication,
reference no.
Type of study; study
population
Focus of study M/F ratio Severity Proposed explanation Other factors/type of analysis
old; 1005 children
with repeated ear
infections in the
previous year
repeated ear
infections
ear infections in the past
year 18%: 15%); OR 1.3
95% CI 1.1–1.5
adenoids, asthma, day care
attendance); MV
Otitis media with effusion
Apostolopoulos
K., 199830
Prospective study;
Greece, 1996; 332
children, 6–12 years
with otitis media with
effusion (OME)
The point prevalence
of OME among school
children
1.4 (194:138); BV analysis:
statistically significant
relationship between OME
and sex, Po0.028
Defected pneumatisation of
the mastoid process in boys
Age, mother’s education,
parental smoking,
breastfeeding, allergy,
previous OM; BV
Chronic otitis media
Vartiainen E.,
199831
Retrospective study;
Finland, 1976–1995;
1123 patients
operated for chronic
OM or its sequels
Changes in the
clinical presentation
of chronic OM from
the 1970s to the
1990s
1.32 (638:485); Male
predominance most
remarkable among
patients with
cholesteatoma (64%
during 1976–1985, 66%
during 1986–1995)
Boys are more prone to acute
OM
Alho O.P., 199532 Retrospective birth
cohort with a 2-year
follow-up; Finland,
births between July
1985 and June 1986
94 children with
chronic otitis media
with effusion (COME)
Risk factors for COME
in infancy
Male sex risk factor for
COME OR 2.17, 95%CI
1.37–5.44
Previous acute otitis media,
attendance at a day nursery,
autumn season MV
Shamboul K.M.,
199233
Prospective study;
Saudi Arabia,
1988–1989; 117
patients with chronic
suppurative otitis
media (CSOM)
An unusual
prevalence of
complications of
CSOM in young adults
1.72 (74:43) Complications of CSOM:
female predominance (1:2)
(brain abscess, lateral sinus
thrombosis, facial palsies)
Late presentation of females
because of social reasons or
undue susceptibility to the
destructive effect of
cholesteatoma (abnormal
bone metabolism due to low
levels of plasma vit. D)
Mastoiditis
Spartley J.,
200034
Retrospective study;
Portugal, 1993–1998;
43 patients
Acute mastoiditis in
children
2.31 (30:13) Age, race, medical history
(repeated tonsillitis, enlarged
adenoids), day care
attendance
Intracranial complications of URTIs
Quraishi H.,
200635
Retrospective study;
USA, 1996–2004; 12
patients, o18 years
Intracranial
complications of
sinusitis in the
paediatric population
5 (10:2)
M
.E.
Falagas
et
al.
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Kurien M., 199836 Prospective study;
India, 1990–1996; 36
patients
Otogenic intracranial
abscess
Children: 2.03:1 (67%
males); adults: 4:1 (80%
males)
Rosenfeld E.A.,
199437
Retrospective study;
Chicago, 1980–1992;
9 patients
Infectious
intracranial
complications of
sinusitis in children
(abscesses)
3.5 (7:2) Age (89% 49 years);
Nunez D.A.,
199038
Retrospective study;
Scotland, 1976–85;
41 patients
Risk of developing an
otogenic intracranial
abscess
3. Po0.01; older males
(440 years) appear to be
more at risk
BV
BV: bivariate analysis, CI: confidence interval, F: female, HR: hazard ratio, M: male, MV: multivariate analysis, OR: odds ratio, RR: risk ratio, URTIs: upper respiratory tract infections.
Sex
d
ifferences
in
resp
iratory
tract
infections
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Table 2 Sex differences in the incidence and severity of lower respiratory tract infections.
First author, year of
publication
Type of study, study
population
Focus of study M/F ratio Severity Proposed explanations Risk factors/type of analysis
Bronchiolitis
Nagayama Y., 200639 Prospective study;
Japan, 1988–2002;
141 children,o 1year
with a first episode
Sex analysis in acute
bronchiolitis due to
RSV
1.76 (90:51); WBC counts
and serum CRP levels at
acute stage higher in girls
(Po0.05). Sputum
eosinophilia in boys (6/42)
exclusively
Sex hormones BV
Papadopoulos N., 200440 Prospective study;
Greece; 81 infants;
0.5–12months;
hospitalised for RSV
bronchiolitis
RSV subtype and
severity of acute
bronchiolitis in
hospitalised infants
1.25 (45:36) Boys had more severe disease
than girls (P ¼ 0.007)
More severe disease in infants
o3 months and in infants
infected with RSV subtype A;
BV
Lowther S.A., 200041 Retrospective study;
Indian Health Service
hospital records,
1990–1995; 7641
bronchiolitis-
associated
hospitalisations, 0–4
years
Bronchiolitis-
associated
hospitalisations
among American
Indian and Alaska
Native children
1.36 (Hospitalisation rate
per 1000 population
12.9:9.5) Hospitalisations
higher among males,
4453:3188
Gupta R., 199642 Retrospective study;
Scotland, 1982–1990;
10,058 hospital
admissions for
bronchiolitis
Sudden infant death
syndrome and
bronchiolitis
1.6 (6177: 3881) Peripheral airways
disproportionately narrow in
the early years of life, more
marked in males
CAP
Thomsen R.W., 200643 Prospective study
Denmark, 1994–2004;
41,793 patients 415
years with a first-time
hospitalisation with
pneumonia
Hospitalised
pneumonia in
Denmark
1.12 (53% of the patients
were male); Overall
incidence rates: 20%
higher in men than
women, and amongst
persons 465 years
50–100% higher in men.
Adjusted mortality rate ratios:
1.15 (95% CI 1.10–1.21) for 30-
day mortality and 1.19 (95% CI
1.14–1.24) for 90-day
mortality
Socio-economic and lifestyle-
related risk factors
For incidence: age For
mortality: age, comorbidity;
MV
O’Meara E.S., 200544 Prospective study;
USA, 1989–1993,
follow-up for 10
years; 582 patients,
465 years
Hospitalisation for
pneumonia in
community-dwelling
older adults
287:295; 1.47 (rate per
1000 person-years
13.7:9.3); male sex risk
factor for hospitalisation
for pneumonia, RR 1.96,
95% CI 1.59–2.42,
Po0.001 (related to the
control population)
Age, comorbidity, lower FEV-1,
smoking, DM MV
Vrbova L., 200545 Retrospective study;
Ontario, 1995–2001;
60,457 patients, 465
years
Socioeconomic status
and mortality
subsequent to
admission for CAP
Women had lower odds of
dying for both 30-day (OR 0.78
Po0.0001) and 1 year
mortality (OR 0.68 Po0.0001)
Age, comorbidity; MV
M
.E.
Falagas
et
al.
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Marrie T.J., 200546 Prospective study;
Canada, 2000–2002;
3065 low-risk patients
with CAP
Low-risk patients
admitted with CAP
0.96 (1498:1567 patients
with CAP) hospitalised
240:346, OR (female vs.
male) 1.34 95% CI
1.06–1.69 P ¼ 0.015
Respiratory rate, substance
abuse, psychiatric illness,
comorbidities, site of care; MV
Jackson M.L., 200447 Retrospective study;
Washington,
1998–2001; patients
465 years; 1266
patients with
hospitalisation for
CAP and 1881 with
outpatient visits for
CAP
The burden of CAP in
seniors
1.25 (no. of cases of CAP
per 1000 person-years
32.2:25.6) Male sex: HR
1.23 (95%CI 1.15–1.33)(all
CAP) 1.34 (hospitalisations
for CAP), 1.19 (outpatient
visits)
Age, current smoking, DM,
congestive heart failure, lung
cancer, COPD; MV
Marrie T.J., 200348 Retrospective study;
Canada, 1991–1999
11,684
hospitalisations
among 10,466
patients, 18–55 years
Factors associated
with death among
adults o55 years
hospitalised for CAP
0.93 (5640:6044 patients
hospitalised for CAP)
Male sex risk factor for CAP-
associated death: Overall
deaths 152 females: 224 males
(F/M OR 0.7). During the 10
days of hospitalisation F/M OR
0.64
Urban residence, aspiration
CAP, comorbidity, age, bigger
hospitals; MV
Aliyu Z.A., 200349 Retrospective
analysis; Maryland,
Jan–Dec 2000; 296
patients, 18–49 years
Determinants for
hospitalisation in low-
risk CAP
Females 2.94 times more
likely to be admitted than
males P ¼ 0.0018; (82% f
vs. 18%m hospitalised,
61%f vs. 39%m discharged)
Women are more likely to rate
their health poor and accept
hospitalisation
Race, insurance coverage,
temperature, pulse rate BV
Mortensen E.M., 200350 Prospective study;
USA, 1991–1994; 1419
of 1555 pneumonia
patients survived for
490 days
Assessment of
mortality after long-
term follow-up of
patients with CAP
Male sex significantly
associated with long-term
mortality. 63% of males: 70.2%
of females survived. Male sex:
HR 1.5 95% CI 1.2–1.8
Age, do-not-resuscitate
orders, poor nutritional status,
comorbid illnesses, lack of
feverishness, nursing home
residence; MV
Kaplan V., 200251 Retrospective study
USA, 1997; 623,718
cases 465 years
Hospitalised CAP in
the elderly
1.2 (incidence rate 19.4
vs. 15.6 cases per 1000
population, Po0.001),
actual numbers;
289,249(46.4%):
334,469(53.6%)
Men had higher mortality,
11.6% vs. 9.8%, Po0.001,
adjusted OR 1.15. Men more
likely to suffer from gram-
negative infections (14.3% vs.
11.5%, Po0.001); Men were
more likely to have a complex
course (24.4% vs. 20.8%,
Po0.001)
Biological factors, differences
in the access to care, sex bias
in the admission decision.
Factors for mortality: age,
residence in a nursing home,
comorbidity. MV
Baine W.B., 200152 Retrospective study;
USA, 1991–1998;
273,143 pneumonia
hospitalisations,
patients, 465 years
Hospitalisation of
elderly Medicare
patients for
pneumonia
Age-adjusted discharge
rates for men invariably
exceeded those for
women (e.g., Pneumonia,
organism unspecified:
annual hospital discharges
per 100,000 persons 65–89
years: 1311m vs. 884f for
black race (Po0.001) and
1293m vs. 920f for white
(Po0.001)
Male sex is risk factor for
cigarette smoking in elderly
Americans
Age, race; BV
Sex
d
ifferences
in
resp
iratory
tract
infections
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Table 2 (continued )
First author, year of
publication
Type of study, study
population
Focus of study M/F ratio Severity Proposed explanations Risk factors/type of analysis
Akbar D.H., 200153 Retrospective study;
Saudi Arabia,
1998–1999; 354
pneumonia (CAP and
HAP) patients of
whom 125 diabetics
Bacterial pneumonia,
comparison between
diabetics and non-
diabetics
3:1 in diabetics vs. 1.2:1
in non-diabetics, Po0.001
Georges H., 199954 Retrospective,
1987–1992, and
prospective study,
1993–1995; ICUs in
France; 505 patients
with severe CAP, 137
of whom with
pneumococcal CAP
Prognosis of severe
community-acquired
pneumococcal
pneumonia
1.97 (335:170 with severe
CAP) Male sex was
independently predictive
of pneumococcal
pneumonia, 3.03 (103:34
patients), P ¼ 0.01;
Lack of antimicrobial agents
before ICU admission, septic
shock, non-aspiration
pneumonia MV
Gordon H.S., 199955 Retrospective study
30 hospitals in
Northeast Ohio,
1991–1993; 17,982
pneumonia patients
The relationship of
sex and in-hospital
death for 6 common
nonsurgical diagnoses
Death rates higher in men than
women for pneumonia (OR
1.16 95%CI 1.02–1.32 P 0.002)
Higher prevalence of
unmeasured risk factors in
men; sex-related variation in
the utilisation of hospital
services; biological differences
MV
Watanakunakorn C., 199756 Retrospective study;
Ohio, 1992–1996; 108
patients (no HAP)
Adult bacteremic
pneumococcal
pneumonia
0.69 (44:64)
Hedlund J., 199757 Prospective study;
Sweden, 1991–1995;
653 patients, 50–85
years
Recurrence of
pneumonia after
hospital treated CAP,
aetiology and
predisposing
conditions
0.92 (313:340) Male sex significantly
associated with higher
mortality (HR 2.71 95% CI
1.48–4.94 P ¼ 0.01)
Age, congestive heart failure,
other chronic diseases; MV
Jokinen C., 199358 Prospective and
retrospective study;
Finland, 1981–1982;
546 cases in 543
persons
Incidence of CAP in
Finland
1.45 (323:223), the male
predominance particularly
strong among children o5
years and the elderly;
incidence per 1000
inhabitants per year: 13.9
in males, 9.4 in females
Mortality higher in men aged
460 years than in women of
the same age (mortality per
1000 inhabitants per year460
years: 4.4 for males, 0.8 for
females)
Nursing-home acquired pneumonia
Sund-Levander M., 200359 Prospective study;
Sweden, 2000–2001;
32 patients with
pneumonia, 466
years
Nursing-home-
acquired pneumonia
in a Swedish
population
OR 3.2 Po0.05; (males
16/78, females 16/156)
COPD, ADL status (activities of
daily living) MV M
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Hutt E, 200260 Retrospective study
USA; 124 patients
with pneumonia
during 1994
Precipitants of
emergency room
visits and acute
hospitalisation in
short-stay Medicare
nursing-home
residents
Males had increased odds
for hospitalisation for
pneumonia; OR 2.74 95%
CI 1.10–6.87 Po0.005
Do not resuscitate orders
negatively associated with
hospitalisation; Comorbid
congestive heart failure
positively associated; MV
Loeb M., 199961 Prospective study;
Ontario, 1993–1996;
155 episodes of
pneumonia in 113
residents
Risk factors for
pneumonia and other
LRTIs in elderly
residents of long-term
care facilities
Male sex risk factor for
pneumonia OR 1.9 95% CI
1.1–3.5 P ¼ 0.03
Age, swallowing difficulty,
inability to take oral
medication, influenzae
vaccination (protective); MV
Nosocomial pneumonia
Sopena N., 200562 Prospective study;
Spain, 1999–2000; 165
patients
Multicenter study of
HAP in non-ICU
patients
2.37 (116:49) Comorbidity, antibiotic
therapy, histamine type 2
blockers, steroids, antacids,
thoracic surgery
Gastmeier P., 200563 Surveillance study;
ICUs in Germany,
1997–2002; 1851
patients with S.
aureus pneumonia
Nosocomial
Staphylococcus
aureus infections in
ICUs
1.84 (64.8%: 35.2%) MV
Lee S.C., 200564 Surveillance study;
Taiwan, 1999–2000;
132 patients with
nosocomial
pneumonia
Risk factors of
mortality for
nosocomial
pneumonia
2.38 (93:39)
Napolitano L.M., 200165 Prospective study;
Maryland, 1983–1995;
848 patients with
pneumonia after
blunt trauma, 18–65
years
Sex differences in
adverse outcomes
after blunt trauma
4.1 (61:15) in the age
45–65 years and ISS 430
subgroup. Males had a
higher incidence of
pneumonia, with the
strongest association in
the age 45–65 years and
ISS 430 subgroup
(Po0.01)
Females with pneumonia were
at significantly higher risk for
mortality (in the 18–45
years–ISS 15–29 subgroup OR
2.76, in the 46–65 years-ISS
430 2001 subgroup OR 5.58)
Sex hormones may play an
important role in the
regulation of post-traumatic
immunosuppression
For the incidence or
pneumonia: age, ISS; MV
Arozullah A.M, 200166 Prospective study
Veterans Affairs
medical centres,
1997–1999; 2466
patients with
postoperative
pneumonia of 160,805
undergoing major
surgery
Predicting
postoperative
pneumonia after
major noncardiac
surgery
2411:55 (98% men) of the
study group (95% men) had
postoperative pneumonia
Po0.001
BV
Vanhems P., 200067 Surveillance study;
ICUs in France,
1994–1996; 628
patients with
nosocomial
pulmonary infection
(NPI)
NPI by antimicrobial-
resistant bacteria of
patients hospitalised
in ICUs
2.39 (443:185) BV
Sex
d
ifferences
in
resp
iratory
tract
infections
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Table 2 (continued )
First author, year of
publication
Type of study, study
population
Focus of study M/F ratio Severity Proposed explanations Risk factors/type of analysis
Crabtree T.D., 199968 Prospective study
Virginia, 1996–1999;
892 patients in the
surgical units with
1470 infectious
episodes—326
pneumonia patients
The role of sex among
hospitalised patients
treated for infection
1.69 (205:121) Mortality higher in women
(men 18%-women 34%, P
0.002) Multivariate: female
sex risk factor for mortality
due to pneumonia (OR for
death 2.25 95%CI 1.17–4.32 P
0.02)
Intrinsic sex differences in the
pathogenesis of disease and
the host’s response to
infection; Difference in
respiratory tract colonisation
in critically ill patients
For pneumonia-associated
mortality: increased APACHE II
score, preexisting malignancy,
DM, time from admission to
diagnosis of infection of 47
days, organ transplantation,
increased age; MV
Kropec A., 199669 Prospective study;
Germany, 1991–1993
129 patients 418
years with NP
Nosocomial
pneumonia (NP) in
ICUs
Male sex risk factor for NP;
RR 2.7 95% CI 1.2–6.3 P
0.021
No infection on admission,
thorax drainage, antacids,
urgent surgery, neurological
diseases; MV
Gomez J., 199570 Retrospective case-
control study; Spain,
1989–1993; 104
patients with NP
Risk factors and
prognosis in non-
ventilated patients
with nosocomial
pneumonia
56:48 vs. 76:28 in the
control group [female sex
risk factor for NP
(P ¼ 0.01)]
Hospital stay 414 days, other
admission in the previous
month, use of antibiotics
during the previous 6 months;
BV
Carratala J., 199471 Prospective
surveillance study;
Spain, 1985–1990; 286
patients with
nosocomial
pneumonia
Risk factors for
nosocomial Legionella
pneumophila
pneumonia
4.2 (231:55 patients with
nosocomial pneumonia)
Leu H.S., 198972 Surveillance study;
Virginia, 1979–1983;
890 patients with
nosocomial
pneumonia
Hospital-acquired
pneumonia
1.87 (580:310)
VAP
Shorr A.F., 200473 Prospective study;
ICUs at USA,
2000–2001; 311
patients with VAP
VAP and red blood cell
transfusion
1.99 (66.6% 33.4%); OR
1.54 (95%CI 1.15–2.07),
P ¼ 0.0042;
Total parenteral nutrition, red
blood cell transfusion,
admission after trauma,
continuous sedation; MV
Bornstain C., 200474 Prospective study
France, 1998–2000;
80 patients, 416
years
Early-onset VAP Male sex risk factor for
VAP; OR 2.06 95%CI
1.18–3.63 P 0.0034
Logistic organ dysfunction
score at day 2, actual GCS
value, use of sucralfate MV
Rello J., 200275 Retrospective study;
ICUs at USA,
1998–1999; 842
patients with VAP
VAP in a large US
database
1/79 (540: 302); OR 1.58,
Po0.001
Male sex may be marker for
other risk factors that
predispose patients to either
colonisation with pathogenic
bacteria or aspiration
Admission after trauma,
severity of illness on admission
MV
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Cook D.J., 199876 Prospective study;
ICUs in Canada 177
patients with VAP
Risk factors for VAP in
critically ill patients
2 (118:59); Male sex risk
factor for VAP, RR 1.43
(95% CI 1.05–1.96) P 0.02
Age, primary admitting
diagnosis, location before ICU
admission (emergency
department), absence of
exposure to antibiotics, low
GCS score, aspiration. BV
Kollef M.H., 199777 Prospective study; St.
Louis, Mar–Jul 1996;
77 VAP patients
Patient transport
from ICU increases
the risk of developing
VAP
1.96 (51:26); Adjusted OR
2.02 95% CI 1.50–2.71 P
0.017
Transport out of the ICU,
reintubation, tracheostomy,
administration of aerosols; MV
Papazian L., 199678 Prospective case-
control study; ICU in
France, 1989–1993;
85 patients with VAP
Effect of VAP on
mortality and
morbidity
2.04 (57:28)
Rello J., 199379 Prospective study;
ICU at Spain; 129 VAP
patients
Impact of previous
antimicrobial therapy
on the aetiology and
outcome of VAP
2.4 (91:38) BV
Rello J., 199280 Prospective study ICU
at Spain, 1988–1990;
91 patients with VAP
Pneumonia due to
Haemophilus
influenzae among
mechanically
ventilated patients
2.25 (63:28 patients with
VAP)
Aspiration pneumonia
Isbister G.K., 200481 Retrospective study;
Australia, 1997–2002;
71 patients
Aspiration
pneumonitis (AP) in
an overdose
population
1.56; (61% of patients with
AP were men, compared
with 39% of overdose
patients without AP being
men, Po0.001). Female
sex associated with a
decreased risk for AP, OR
0.49 95% CI 0.29–0.82
Age, GCS, emesis, seizure,
tricyclic antidepressants co-
ingestion; MV
Aslanyan S., 200482 Prospective study;
Multicenter 198
patients developed
aspiration pneumonia
Pneumonia and UTIs
after acute ischaemic
stroke
Male sex risk factor for
aspiration pneumonia; OR
1.71 95% CI 1.22–2.39
Higher baseline National
Institute of Health Stroke
Scale, age, history of diabetes,
stroke subtype; MV
Kozlow J.H., 200383 Retrospective study;
Maryland, 1999–2000;
2636 patients with AP
Aspiration pneumonia
(AP) in patients
undergoing surgery
Male sex risk factor for AP,
OR (for females) 0.5 95%
CI 0.5–0.6
Age, race, admission from the
emergency room, dementia,
COPD, DM, renal disease; MV
Lung abscess
Hagan J.L., 198384 Retrospective study;
Hospital of University
of Mississippi;
1960–1982; 184 cases
Lung abscess 4.26 (149:35) Proximal obstructive
carcinoma, alcoholism, DM,
seizure disorders, post-
traumatic; BV
Empyema thoracis
Hacimustafaoglou M., 200685 Prospective study;
Turkey; 80 children
42 months with
parapneumonic
effusion
Evaluation of
parapneumonic
effusion in childhood
1.42 (47/33) BV
Sex
d
ifferences
in
resp
iratory
tract
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Table 2 (continued )
First author, year of
publication
Type of study, study
population
Focus of study M/F ratio Severity Proposed explanations Risk factors/type of analysis
Angelillo-Mackinlay T.A.,
199686
Retrospective
(1985–1991) and
prospective
(1992–1994) study;
Argentina; 64 patients
Loculated post
pneumonia empyema
2.04 (43:21) BV
Fajardo J.E., 198787 Retrospective study;
USA, Military
Hospitals, 1978–1982;
104 patients 0–18
years
Pleural empyema in
children
(nontuberculous)
2.15 (71:33) Mortality (8 patients) 6:2 Predisposing factors:
pneumonia, multiple trauma,
leukaemia, severe burns
LRTIs
Hak E., 200488 Retrospective study;
The Netherlands,
1998–2000; 455
patients 460 years
with a first LRTI
episode
Community-acquired
LRTIs among the
elderly, factors for
serious morbidity and
mortality
0.82 (45%: 55%); Male sex risk factor for serious
morbidity and mortality, OR
3.12 95% CI 1.66–5.87 Po0.001
There is not valid information
on smoking behaviour of the
patients
Age, heart failure, dementia/
stroke, antidepressants,
diagnosis pneumonia; MV
Lovering A.M., 200189 Prospective study;
UK, 1994–1996; 704
LRTI episodes in 613
patients
Patients hospitalised
for LRTIs
Hospital stays in days
significantly longer for
men (16.1 for men: 12.6
for women)
Marital status, diabetic status,
type of infection; MV
Dharmage S.C., 199690 Case control study;
Sri Lanka; 100
patients o5 years
Risk factors of acute
LRTIs in children
(lobar pneumonia,
bronchopneumonia,
bronchiolitis)
Male sex increased the risk
of acute LRTI, OR 2.5
P ¼ 0.04
History of wheezing, low birth
weight, passive smoking,
delivery by caesarean section;
MV
Kofteridis D.P., 200491 Prevalence study-
cross sectional;
Greece, 1999 and
2000; 200 nos. LRTIs
Nosocomial LRTIs in
14 Greek hospitals
Male gender risk factor OR
1.37 95% CI 1.03–1.83
Po0.05
Age, mechanical ventilation,
intratracheal tube,
tracheostomy; MV
APACHE: acute physiology and chronic health evaluation, BV: bivariate analysis, CAP: community-acquired pneumonia, CI: confidence interval, COPD: chronic obstructive pulmonary
disease, DM: diabetes mellitus, F: female, GCS: Glasgow Coma Scale, HR: hazard ratio, ICU: intensive care unit, ISS: injurie severity score, LRTIs: lower respiratory tract infections, M:
male, MV: multivariate analysis, NP: nosocomial pneumonia, OR: odds ratio, RR: risk ratio, VAP: ventilator-associated pneumonia.
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from the throat.
Tonsillitis: No study is available regarding the incidence
of a first episode tonsillitis. On the other hand, the data
regarding the course, severity, and complications of
tonsillitis are contradictory. Thus, females seem to suffer
more episodes of recurrent tonsillitis10 and therefore
undergo more tonsillectomies.12 On the other hand, males
seem to suffer more episodes of peritonsillar abscesses.11
Sinusitis: Data on both acute and chronic sinusitis are
available. It seems that both entities are more prevalent in
females.13,14,16 The clinical course of the disease also seems
to be longer in females.15
Croup and epiglottitis: The studies regarding croup
include children, whereas those regarding epiglottitis
include adult patients. A large retrospective study on
hospitalised children with croup17 reported that male
patients were significantly more than female patients
(69.3% of all hospitalisations for croup were males).
Although age was also a significant factor for acquisition of
croup, males suffered more episodes of the infection in both
studied age groups (children 0–1 and 1–4 years old). On the
other hand, there are limited data regarding sex differences
on the development and severity of epiglottitis. However,
the two retrieved studies20,21 reported that epiglottitis was
more common in males.
Otitis externa, otitis media and mastoiditis: Two
studies22,23 were available for patients with otitis externa.
The results of the bigger one23 (approximately 30,000
patients) suggest that otitis externa is more common in
females. In addition, persistent infection was marginally
more common in females (P ¼ 0.06), but males exhibited
more episodes of recurrent infection (P ¼ 0.001). On the
other hand, the incidence of otitis media was higher in
males in all the available studies, all but two of which
include children populations.24–33 This was evident for both
acute and chronic form of the infection. These studies also
suggest that male sex is also a risk factor for more severe
infection, more episodes of recurrent acute otitis media,
and higher probability for transition to chronic disease.
Finally, limited data are available for sex differences in
patients with mastoiditis; the single available study34
reported that the male to female ratio for this infection
was 2.31 in children.
Intracranial complications of URTIs: Four studies35–38
reported outcomes of intracranial complications of URTIs.
All four of them included a small number of patients.
However, all of them reported that these complications
were more common in males than in females. The male to
female ratio in these studies ranged from 2 to 5.
Bronchiolitis: Children between 0 and 4 years were
enrolled in the available studies39–42 that examined the
prevalence and severity of bronchiolitis. The data from
these studies suggest that bronchiolitis is more frequent in
boys than in girls. Boys were also more commonly
hospitalised than girls.41 A small study that enrolled infants
also concluded that the disease was more severe in males.40
Community-acquired pneumonia (CAP): Several stu-
dies43–58 were performed regarding the potential risk factors
for development of CAP. Most of them enrolled hospitalised
patients. In most of these studies (and especially in the
larger ones), men were statistically more frequentlyenrolled and in some of them male sex was a risk factor
for CAP or hospitalisation for CAP. Moreover, a study showed
that diabetic males are at increased risk for acquisition of
CAP than diabetic females, while this was not so evident
between non-diabetic males and females.53 In addition,
male sex was a predictor of worse outcome in terms of
duration of hospitalisation, more complex course of CAP, and
mortality. Interestingly, more women were enrolled and/or
hospitalised more frequently in studies that were performed
on patients with milder cases of CAP.46,49
Nursing home-acquired pneumonia (NHAP): Three studies
were available for nursing home residents. Two of
these studies reported that male sex was a risk factor
for development of NHAP.59,61 The third study reported
that males were more commonly hospitalised for this
condition.60
Nosocomial pneumonia (NP): Several studies62–72 exam-
ined the factors that are associated with development and
outcome of NP. In almost all of them NP developed more
frequently in men, while several studies also reported that
male sex was a risk factor for development of NP. The study
by Arozullah et al.66 was conducted in military hospitals and
therefore enrolled 98% men. The male to female ratio
regarding NP in this study was 2.19. Interestingly, the
outcomes of one single study70 were exactly the opposite;
female sex was the risk factor for development of NP. On the
other hand, two studies65,68 that studied predictors of
mortality in patients with NP reported that female sex was
an independent risk factor for mortality.
Ventilator-associated pneumonia (VAP): Several stu-
dies73–80 were designed to identify factors that are
associated with the development of VAP and the available
data suggest that males develop VAP more frequently than
females. Some of these studies also reported that male sex
was a risk factor for VAP. Unfortunately, no data are
available regarding the severity of VAP (in terms of mortality
or duration of hospitalisation due to VAP) according to males
and females.
Aspiration pneumonia (AP): The role of sex for the
development of AP was studied in different patient
populations (patients with stroke, patients undergoing
surgery).81–83 However, all of these studies concluded that
male sex is a risk factor for the development of AP.
Lung abscess and empyema thoracis: The single available
study84 suggested that lung abscess develops more often
in men than in women. The studies that examined pati-
ents with empyema thoracis85–87 came up to the same
conclusions.Evaluation of the reviewed evidence
Overall, the available data suggest that males develop RTIs
more frequently than females, except for sinusitis, otitis
externa, and probably tonsillitis. In addition, male sex was
frequently found to be a risk factor (and for specific
infections like CAP a significant risk factor) for the
development of RTIs. Moreover, the available data suggest
that male sex is not only a predictor of worse outcome for
CAP (as concluded in the meta-analysis by Fine et al.92) but
also for several other RTIs. The available data also suggest
that the higher prevalence of RTIs in males is more obvious
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pneumonia (CAP, NP, and VAP) and croup. On the contrary,
mortality of NP is higher in females. Finally, it seems that
the intracranial complications of the URTIs are probably
commoner in males than in females.Possible explanatory mechanisms of the
observed differences
It should be mentioned that in trying to investigate the role
of sex in the incidence and severity RTIs, population-based
studies might be less susceptible to various sources of
biases, including selection bias. We think that several
factors may play a role in the development and the course
of RTIs. Anatomic differences of the respiratory tract may
partially explain the different prevalence of specific infec-
tions between males and females. More specifically, females
have smaller ostia of the paranasal sinuses and therefore
may be more susceptible to sinusitis.14 On the other hand,
the defected pneumatisation of the mastoid process may
explain the more frequent and severe ear infections in male
children.30 There is also evidence that the peripheral
airways are disproportionately narrower during the early
years of life in males, which may predispose for lower RTIs.42
Several socioeconomic and behavioural factors probably
also play a role in the development of infections and may
partially explain the observed differences.93 A significant
proportion of women work in low salary, part-time, non-
union jobs that do not provide health insurance. Moreover, a
lot of them lose their health insurance after a divorce or the
death of their husband. The available evidence suggest that
currently almost one-third of the families headed by women
in the United States live in poverty; and the fraction is
higher for African-American women and women of Latin
origin.7 These economic differences can either explain the
observed variations in the development of RTIs or give rise
to false conclusions. In the first case, the access to health
care is limited for women who live in poverty and therefore
the probability for enrolment to studies becomes smaller. In
the second case, poverty is associated with poor hygiene,
limited knowledge of and access to disease prevention
(vaccination and transmission) and thus, higher probability
of exposure to infectious micro-organisms.
In addition, lifestyle factors, for example, smoking is a
habit that is more common in males, although the
prevalence in women rises continuously.94–96 Smoking is
associated with several diseases of the respiratory tract
(e.g. cancer, chronic obstructive pulmonary disease, etc.)
that predispose to infections. In addition, smoking activates
a process that destroys the epithelium of the upper airways,
a fact that eliminates the normal washout of potential
pathogens.
Socially defined sex roles can also provide explanation for
the findings. The perception of disease severity is different
between males and females. Women may seek more easily
health care for mild diseases, such as tonsillitis and
pharyngitis, which can explain the higher prevalence of
these diseases in females. Furthermore, women tradition-
ally tend to spend more time than men with their children,
thus exposing themselves to the URTIs that are commonly
found in children.Special attention should be paid to biological differences
and mainly to sex hormones. Steroid sex hormones are
responsible for a variety of actions during the activation of
the immune system. In general, estrogens at physiological
concentrations are thought to play an immune-stimulating
role by upregulating both cellular and humoral immunity,
whereas androgens have an anti-inflammatory impact.97
Most of the available data on this issue come from patients
with autoimmune diseases. In both sexes, adrenal hor-
mones, that is, glucocorticoids, dehydroepiandrosterone
(DHEA), and androgens, are inadequately low in patients
with autoimmune diseases when compared to healthy
controls.98 In addition, female animals appear to have more
vigorous immune response.7 In humans, the administration
of 17b-estradiol stabilises or increases immune stimuli-
induced secretion of TNF, IL-2, IL-4, IL-6, IL-10, and IFNg
from the peripheral blood leucocytes of healthy males in
relation to testosterone. Testosterone, in contrast, inhibits
(IL-2, IL-4, IL-10) or tends to inhibit stimulated secretion of
these cytokines (TNF, IFNg).97
Although these differences in circulating sex hormones
could explain (at least in part) the reported differences in
the incidence and severity of RTIs between males and
females, the apparent differences between boys and girls
remain without an answer, since the role and the concen-
tration of sex hormones are not so prominent in the early
years of life. Another fact that may question the findings is
that several chronic diseases like diabetes mellitus or
autoimmune diseases, and chronic conditions like obesity
that compromise the function of the immune system are
more commonly found in women. Although the epidemiology
of cancer and other chronic diseases of the respiratory tract
have changed during the last decades (mainly as a
consequence of smoking habits and exposure to air
pollutants), their role should also be significant in the
development and outcome of RTIs.
Limitations in interpreting the reviewed
evidence
It should be acknowledged that there are various sources of
limitations in interpreting the findings of this review. The
studies included in our review used various methodologies.
In addition, the source of the study populations was not
always clarified. It should also be mentioned that someone
could have used a different scheme for the classification of
the infections in URTIs and LRTIs; although the glottis is
anatomically considered the point of separation between
the upper and lower respiratory tract, we classified croup in
the URTIs as it is done in most infectious diseases textbooks.
Another noteworthy limitation in the interpretation of the
findings of our review is that the studies included in our
article were heterogeneous to some degree regarding
disease definitions, geographical differences, and the age
of study populations.
Conclusion
There are significant sex differences in the development,
course, and outcome of RTIs. Compared to females, males
seem to suffer more commonly from most types of RTIs.
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Sex differences in respiratory tract infections 1861In addition, most RTIs take a more severe course in males,
leading to higher mortality. Clinicians should be aware of
these differences and take them under consideration when
managing patients with RTIs, for example by being alert to
diagnose an intracranial complication, which seems to be
more often in males, after a URTI episode, or when treating
patients with CAP they should keep in mind the higher
mortality of male patients. Also, it seems prudent that
future studies on the incidence and severity of RTIs should
pay more attention to a traditionally important epidemio-
logical characteristic of patients: the sex.
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